Piyush Trivedi Selected Research

Colonic Neoplasms (Colon Cancer)

1/2018	lH-Pyrazolo[3,4-b]quinolin-3-amine derivatives inhibit growth of colon cancer cells via apoptosis and sub G1 cell cycle arrest.
1/2016	Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells.
2/2015	IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piyush Trivedi Research Topics

Disease

25	Neoplasms (Cancer) 01/2023 - 11/2009
3	Lymphoma (Lymphomas) 11/2022 - 05/2015
3	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 01/2018 - 02/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2014 - 03/2011
2	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 05/2019
2	Breast Neoplasms (Breast Cancer) 07/2021 - 04/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2021 - 03/2016
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Obesity 01/2018 - 10/2011
2	Ovarian Neoplasms (Ovarian Cancer) 06/2017 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 05/2014 - 03/2014
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2012 - 01/2012
2	Edema (Dropsy) 03/2009 - 07/2008
1	Carcinogenesis 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021
1	Inflammation (Inflammations) 01/2020
1	Brain Neoplasms (Brain Tumor) 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 02/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016
1	Carcinoma (Carcinomatosis) 02/2015
1	Weight Gain 09/2012
1	Cardiotoxicity 04/2012

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 03/2011
4	TubulinIBA 11/2021 - 03/2016
3	EnzymesIBA 01/2023 - 03/2014
3	quinolineIBA 11/2022 - 02/2015
3	Colchicine FDA LinkGeneric 11/2021 - 03/2016
3	ChalconesIBA 11/2021 - 01/2015
3	Silybin (Lagosa)IBA 01/2018 - 01/2017
3	methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo(d)imidazole-5-carboxylateIBA 04/2017 - 03/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 01/2012
2	QuinolonesIBA 11/2021 - 01/2017
2	anilinoquinazolineIBA 07/2021 - 03/2014
2	Chalcone (Benzalacetophenone)IBA 07/2021 - 01/2015
2	pyrimidineIBA 05/2019 - 09/2017
2	Insulin (Novolin)FDA Link 01/2018 - 09/2012
2	imidazoleIBA 04/2017 - 03/2016
2	benzimidazoleIBA 02/2017 - 03/2016
2	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 01/2017 - 01/2016
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2016 - 02/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 05/2015
2	Imiquimod (Aldara)FDA LinkGeneric 06/2014 - 05/2014
2	CarrageenanIBA 03/2009 - 07/2008
2	Acetic Acid (Vinegar)FDA LinkGeneric 03/2009 - 07/2008
2	Analgesics (Analgesic Drugs)IBA 03/2009 - 07/2008
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2023
1	Cyclin-Dependent Kinase 9IBA 01/2023
1	IgA receptor (protein B)IBA 11/2022
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2022
1	Janus KinasesIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	CytokinesIBA 01/2022
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2022
1	ABT-737IBA 11/2021
1	FlavonoidsIBA 01/2020
1	thienopyrimidineIBA 05/2019
1	CateninsIBA 05/2019
1	Small Interfering RNA (siRNA)IBA 03/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2018
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2018
1	ChromatinIBA 01/2018
1	AminesIBA 01/2018
1	Annexin A5IBA 01/2018
1	LeptinIBA 01/2018
1	Tubulin ModulatorsIBA 06/2017
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2017
1	benzocycloheptapyridineIBA 01/2017
1	multidrug resistance-associated protein 1IBA 01/2017
1	N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Dopamine D3 ReceptorsIBA 01/2017
1	Vinca AlkaloidsIBA 03/2016
1	QuinolinesIBA 01/2016
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2016
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2016
1	nilotinib FDA Link 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 05/2015
1	stearidonic acidIBA 05/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Serine (L-Serine)FDA Link 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	Phosphotransferases (Kinase)IBA 05/2014
1	Protein Kinases (Protein Kinase)IBA 03/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2012
1	2,4-thiazolidinedione (thiazolidinedione)IBA 09/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2012
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2012
1	Peptides (Polypeptides)IBA 04/2012
1	LigandsIBA 04/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2012
1	Octreotide (Sandostatin)FDA LinkGeneric 04/2012
1	caprolactoneIBA 01/2012
1	Progesterone FDA LinkGeneric 10/2011

Therapy/Procedure

8	Therapeutics 01/2023 - 04/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2012